Association between CRP gene polymorphisms and the risk of preeclampsia in Han Chinese women

Yuting Wang1, Qidi Wang, Changlong Guo

  • 11 Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University , Shenyang, China .

Insights

Genetic variants in C-reactive protein (CRP) are linked to preeclampsia (PE) risk in Chinese women. The CRP rs2794521 TT genotype significantly increases the odds of developing PE.

Area of Science:

  • Genetics and Molecular Biology
  • Reproductive Medicine
  • Inflammation Research

Background:

  • C-reactive protein (CRP) is an inflammatory marker with elevated expression in preeclampsia (PE).
  • The role of CRP genetic variants in PE pathogenesis remains largely unexplored.
  • This study investigates the association between CRP polymorphisms and PE risk in Han Chinese women.

Purpose of the Study:

  • To assess the genetic association between specific C-reactive protein (CRP) polymorphisms and the risk of preeclampsia (PE).
  • To evaluate the impact of CRP genetic variants on PE susceptibility in Han Chinese women.

Main Methods:

  • Genotyping of five single-nucleotide polymorphisms (SNPs) in the CRP gene: rs2794521, rs3091244, rs3093068, rs876538, and rs1205.
  • Utilized the Sequenom method for genotyping in a cohort of 181 PE patients and 203 healthy controls.
  • Analyzed allele and genotype frequencies, and assessed haplotype associations.

Main Results:

  • The T allele of CRP rs2794521 was significantly more frequent in PE patients (OR=4.091, p=0.002).
  • The TT genotype of rs2794521 conferred a 4.062-fold increased risk for PE (p=0.003) and a 9.577-fold risk for severe PE (p=0.006).
  • The CRP H2 haplotype (T-C-C-G-C) was associated with increased PE risk (OR=2.129, p<0.001), while H1 (C-C-C-G-C) showed a protective effect (OR=0.23, p=0.01).

Conclusions:

  • The CRP genetic variant rs2794521 is strongly associated with preeclampsia risk in Han Chinese women.
  • Pregnant women with the TT genotype of rs2794521 exhibit a significantly higher likelihood of developing PE.
  • These findings support a potential role for CRP in the molecular mechanisms underlying preeclampsia.
Abstract

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
748
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
152
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.1K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
113
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
46.0K